Evidence map›Paper›PMID 27635286›Full record

ArticleTurkish journal of urology2016

The level of knowledge and awareness about prostate cancer in the Turkish male and the relevant effective factors.

Sadi Turkan, Faruk Doğan, Ozan Ekmekçioğlu, Aslıhan Çolak, Mehmet Kalkan, Çoşkun Şahin

Open access · bronzeAbstract read
In one paragraph

Article in Turkish journal of urology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact, top 97% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Sadi TurkanClinic of Urology, Kastamonu Anadolu Hospital, Kastamonu, Turkey.
Faruk DoğanDepartment of Urology, Fatih University School of Medicine, İstanbul, Turkey.
Ozan EkmekçioğluClinic of Urology, Kastamonu Anadolu Hospital, Kastamonu, Turkey.
Aslıhan ÇolakDepartment of Internal Diseases, Fatih University School of Medicine, İstanbul, Turkey.
Mehmet KalkanDepartment of Urology, Fatih University School of Medicine, İstanbul, Turkey.
Çoşkun ŞahinDepartment of Urology, Fatih University School of Medicine, İstanbul, Turkey.
Fatih University · TRKastamonu University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveOur aim was to determine the general knowledge and awareness levels, information sources, and the state of medical check-up for prostate cancer (PCa) and relevant effective factors. MATERIAL AND

methodsThe participants were asked to answer to 14 questions of a questionnaire about age, education, economic and social condition, knowledge about PCa, state of being examined and their related factors. According to demographic characteristics of the participants, levels of awareness about PCa, sources of information, affecting factors and their interrelationships were examined. Two groups were formed according to age (<60 years, >60 years) and variations according to ages were investigated.

resultsTwo hundred and ninety-three men with an average age of 57 years (range 40-85) were included in the study. Our findings showed that 68.3% of the participants were thinking that PCa is a frequently seen disease, 88.4% were thinking that it can be treated and 62.8% of men specified that their information sources are doctors. We also found that 60.8% of the participants had not undergone prostate examination and prostate specific antigen (PSA) control. The most reason for not having annual examinations was (44.4%) "negligence". Significantly greater number of men with higher education (high school/university) were highly informed about PCa (p=0.037). Check-up rates were statistically significantly higher among men with intermediate income (p=0.041). Curability of PCa diagnosed at an early stage was acknowledged by statistically higher number of individuals under the age 60 (p<0.05). Health control, prostate examination and/or PSA control rates were higher in men with a family history of PCa and in the group of >60 years.

conclusionAlthough PCa has a high prevalence and mortality rates, personal and social information and sensitivity levels must be increased as it can be treated if diagnosed at an early stage. We think that social and medical impact of the disease can be decreased with the planning of effective methods based on sociocultural and economic factors.

Indexed as

Awarenessmaleprostate cancer

Identifiers

PMID27635286
PMCPMC5012438
OpenAlexW2325307758

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.